-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, R7rDRTe+h4DyAgScSUVux/03WdTh3l+9usMC7z1jnrX0D7kjVfpCb72v9HkY7dkK Cph6lhNIdFv9KM1faHgkfg== 0001127602-10-024046.txt : 20100929 0001127602-10-024046.hdr.sgml : 20100929 20100929190834 ACCESSION NUMBER: 0001127602-10-024046 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100927 FILED AS OF DATE: 20100929 DATE AS OF CHANGE: 20100929 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GALLAGHER MICHAEL R CENTRAL INDEX KEY: 0001158587 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10269 FILM NUMBER: 101097631 MAIL ADDRESS: STREET 1: C/O PLAYTEX PRODUCTS INC STREET 2: 300 NYALA FARMS ROAD CITY: WESTPORT STATE: CO ZIP: 06880 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALLERGAN INC CENTRAL INDEX KEY: 0000850693 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 951622442 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2525 DUPONT DRIVE CITY: IRVINE STATE: CA ZIP: 92612 BUSINESS PHONE: 7142464500 MAIL ADDRESS: STREET 1: P.O. BOX 19534 CITY: IRVINE STATE: CA ZIP: 92713-9534 4 1 form4.xml PRIMARY DOCUMENT X0303 4 2010-09-27 0000850693 ALLERGAN INC AGN 0001158587 GALLAGHER MICHAEL R 2525 DUPONT DRIVE IRVINE CA 92612 1 Phantom Stock Units 2010-09-07 5 A 0 E 12.7 63.58 A Common Stock 12.7 16158.94 D Phantom Stock Units 2010-09-27 4 A 0 15.11 66.17 A Common Stock 15.11 16174.05 D Phantom Stock Units 2010-09-27 4 A 0 15.11 66.17 A Common Stock 15.11 16189.16 D Phantom Stock Units 2010-09-28 4 A 0 29.94 66.80 A Common Stock 29.94 16219.1 D Converts to common stock on a 1-for-1 basis. Phantom stock units acquired under the Allergan, Inc. Deferred Directors' Fee Program in lieu of cash for quarterly dividend, exempt transaction under Rule 16a-11. Phantom stock units are to be settled 100% in stock upon the reporting person's retirement as an Allergan, Inc. director. Phantom stock units acquired under the Allergan, Inc. Deferred Directors' Fee Program in lieu of cash for meeting fees. /s/ Matthew J. Maletta, Attorney-in-Fact for Michael R. Gallagher 2010-09-29 -----END PRIVACY-ENHANCED MESSAGE-----